News By Tag
News By Location
SMi's 4th Annual Ophthalmic Drugs Conference - Chairman's Invitation Released
SMi Group reports: Chairman of the 4th Annual Ophthalmic Drugs conference has invited experts in the industry to join.
By: SMi Group
With 50% of the global population predicted to have complications in their sight within the next few decades, ophthalmic medicine is set to become one of the biggest industries in pharmaceuticals. The global ophthalmic drug market is forecast to surpass $60 billion USD by 2025 with increasing focus from the industry on alternative delivery approaches and improving the effectiveness of the current repertoire of drugs in order to grow away from intravitreal injections and other surgical approaches to ocular therapy.
The Ophthalmic Drugs conference will bring together expertise from individuals in multiple disciplines of the field. The packed two-day agenda will offer a series of presentations, through which you will gain insight into new industry developments and clinical trials, innovations in the treatment of rare diseases, regulatory perspectives, and advances in gene therapy. Furthermore, the workshop day will explore the growing industry focus on the development of novel methods of ocular drug delivery, giving an unmissable insight into this emerging field of drug development.
Attendees stand to gain many valuable insights from this event, such as:
Big Pharma & Biotech Speakers:
To find out more and view the full agenda for the day please visit www.ophthalmicdrugs.com/
Mitchell de Long
Vice President, Chemistry
(Conference Chairman for Ophthalmic Drugs)
Proudly Sponsored by Experimentica & TALLC